Carregant...
Combination Metronomic Oral Topotecan and Pazopanib: A Pharmacokinetic Study in Cancer Patients with Gynecological Cancer
BACKGROUND: Combination metronomic topotecan plus pazopanib is active against preclinical models of gynecologic cancer. Both agents are substrates for ATP-binding cassette family transporters so there is an increased likelihood for pharmacokinetic (PK) drug drug interactions. PATIENTS AND METHODS: P...
Guardat en:
| Publicat a: | Anticancer Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386652/ https://ncbi.nlm.nih.gov/pubmed/24023315 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|